Extending mechanistic investigations on CCL24 may raise enticing therapeutic opportunities for abrogating the transdifferentiation of VSMCs into osteoblast/chondrocyte-like cells to prevent vascular calcification in atherosclerosis. This evidence concerns the gene CCL24 and atherosclerosis.